Sender CO & Partners, Inc. Aveo Pharmaceuticals, Inc. Transaction History

Sender CO & Partners, Inc.

  • $41.4 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 17, 2022
SELL
$3.15 - $6.01 $289,881 - $553,076
-92,026 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$4.69 - $7.4 $431,601 - $680,992
92,026 New
92,026 $432,000

Others Institutions Holding AVEO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AVEO PHARMACEUTICALS, INC.

AVEO Quotes by TradingView
  • Ticker AVEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,676,000
  • Description
  • AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...
More about AVEO
Track This Portfolio

Track Sender CO & Partners, Inc. Portfolio

Follow Sender CO & Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sender CO & Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sender CO & Partners, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email